<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>We present two cases of severe <z:hpo ids='HP_0002315'>headache</z:hpo> associated with the use of <z:chebi fb="0" ids="3181">bromocriptine</z:chebi> for lactation suppression in otherwise healthy women </plain></SENT>
<SENT sid="1" pm="."><plain>In each case, the additional use of a therapeutic <z:chebi fb="0" ids="35524">sympathomimetic agent</z:chebi> resulted in extreme worsening of symptoms with development of <z:hpo ids='HP_0000822'>hypertension</z:hpo> and life-threatening complications (<z:hpo ids='HP_0004756'>ventricular tachycardia</z:hpo> and cardiac dysfunction in one case, <z:hpo ids='HP_0001250'>seizures</z:hpo> and <z:e sem="disease" ids="C0265110" disease_type="Disease or Syndrome" abbrv="">cerebral vasospasm</z:e> in the other) </plain></SENT>
<SENT sid="2" pm="."><plain><z:chebi fb="0" ids="35524">Sympathomimetics</z:chebi> in combination with <z:chebi fb="0" ids="3181">bromocriptine</z:chebi> in patients with a <z:chebi fb="0" ids="3181">bromocriptine</z:chebi>-associated <z:hpo ids='HP_0002315'>headache</z:hpo> during the puerperium may be dangerous </plain></SENT>
</text></document>